The Provant Wound Closure System induces activation of p44/42 MAP kinase in normal cultured human fibroblasts.
Gilbert
Terri L
TL
Regenesis Biomedical Inc., 1435 N Hayden Road, Scottsdale, AZ 85257, USA.
Griffin
Nicole
N
Moffett
John
J
Ritz
Mary C
MC
George
Frank R
FR
D001672:Biocompatible Materials / Q000494:pharmacology*; D015153:Blotting, Western; D002455:Cell Division; D002478:Cells, Cultured; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005347:Fibroblasts / Q000201:enzymology* / Q000528:radiation effects; D005419:Flavonoids / Q000494:pharmacology; D006801:Humans; D020935:MAP Kinase Signaling System; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D011846:Radio Waves; D013997:Time Factors; D014945:Wound Healing
D001672:Biocompatible Materials; D004791:Enzyme Inhibitors; D005419:Flavonoids; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one